Skip to main content

Preventing Surgical Site Infections: Are we swabbing/treating the wrong orifice? by Steven P. LaRosa, M.D.




A few Friday afternoon consults for prosthetic joint infections got me thinking about the whole issue of preventing surgical site infections (SSI). It is quite common in cardiothoracic surgery and orthopaedic surgery for patients to be screened pre-operatively for Staphylococcus aureus colonization with a nasal culture or PCR. Those who are positive are prescribed nasal Mupirocin to rid the carrier state in hopes of decrease the risk of SSI. Additionally, since patients can carry S. aureus elsewhere (axilla, inguinal, perirectal) patients are instructed to bathe with Chlorhexidene pre-operatively. Despite these decolonization attempts one study showed that 20% of patients remained colonized with MRSA and continued to have SSIs (Baraz et al. Clin Orthop Related Res 2015).

What occurred to me in a review of the literature is that maybe we are focusing on the wrong site of colonization. Approximately 20% of people have intestinal colonization of the gastrointestinal tract. This can be measured by culture of the stool, or swab cultures taken from the inguinal, perineal or perirectal areas. While nasal and intestinal colonization often go together, 10% of all colonized patients will only be colonized intestinally, and one in three patients colonized intestinally have negative nasal cultures. This raises the issue that we are missing a lot of colonized patients by just assessing the nares. Furthermore, given the proximity of the anus to a potential prosthetic hip or knee joint it raises the critical importance of cleaning the perineal and peri-rectal areas preoperatively. I would suggest that this is so important that we probably should not leave this to the patients but should have thorough wiping of these areas in the preoperative area with Chlorhexidene wipes (“nose to toes disinfection”).

A new hypothesis on the development of surgical site infections also indicates that we should be paying more attention to intestinal colonization with Staphylococcus aureus. In a study by Krezalek and colleagues (Ann Surg. 2017 Feb 9) mice who had their guts colonized with MRSA prior to a partial hepatectomy, and trauma to the rectus muscle developed infections at the rectus muscle surgical site. Mice that had their surgical wounds painted with MRSA or had MRSA administered intravenously did not develop infections at the rectus muscle surgical site. Circulating neutrophils from mice captured by flow cytometry demonstrated MRSA in their cytoplasm. This raises the possibility that gut derived MRSA are carried via neutrophils (Trojan horse) serve as a mechanism of surgical site.

The gut hypothesis of surgical site infection is testable. Patients could be screened pre-operatively for intestinal colonization with Staph aureus via a peri-rectal swab. As systemic antibiotics have little effect on decreasing intestinal colonization, patients found to be positive for S. aureus could be randomized to oral Vancomycin or placebo in addition to standard of care. A previous study has demonstrated that Vancomycin given orally at a dose of 250mg every 6 hours for 5 days is effective at eradicating gut colonization. Repeat per-rectal swabs could be obtained at the time of surgery and PJI event rates could be calculated.


Comments

  1. They say the spiritual control the physical, you have to understand that is true seeing what is happening around the world today you will see that it beyond the physical realm, so I have to protect my family members and myself from contacting this virus with protection spell. You too can protect your family and yourself from contacting the virus today with the protection spell. Contact Dr. Ekpen Temple today for the spell at ekpentemple@gmail.com.

    ReplyDelete

Post a Comment

Popular posts from this blog

"I'm Throwing you (ID) Pearls Here" by Steven P. LaRosa, M.D.

Prior to me employed by a non-academic teaching hospital I spent 11 years teaching Infectious Disease to medical students, Internal Medicine residents and ID fellows at 3 different academic teaching hospitals. I had a vast array of clinical pearls that I would share on teaching rounds. In my last 5 years in a non-teaching setting I am often amazed that no one ever taught physicians who are Board Certified in Internal Medicine these important teaching points. I thought it might be useful to share some of my favorite ID teaching points or "pearls" in this blog. 1) oral Beta lactam agents are not adequate treatment of bacteremia 2) Beta-lactam- beta lactamase drugs (Unasyn, Zosyn) and Carbapenems (Ertapenem and Meropenem) have perfectly adequate anaerobic coverage and do not require the addition of Metronidazole 3) Oral vancomycin has no bioavailability 4) Vancomycin is inferior to Beta lactam drugs for the treatment of serious MSSA infections 5) When awaiting sensiti

"The Viral Hypothesis of Alzheimer's Disease: Time to put it to the test!" by Steven P. LaRosa, M.D.

Alzheimer’s disease (AD) was estimated to affect 35.5 million people worldwide in 2010 and is expected to affect 115.4 million people by 2050. Approximately 10% of people over 65 are affected and 50% of population > 85 are affected. The currently approved drugs provide minimal benefit. The benefit of experimental drugs observed in Phase II clinical trials has been followed by resounding failures in adequately powered Phase III clinical trials. Even the results of the highly publicized Biogen study have significant questions associated with it. It is quite clear that a new strategy must be entertained and tested. Four members of the Human Herpes Virus family have been associated with development of Alzheimer’s disease; HSV-1, VZV, HHV-6A, and HHV-7. HSV-1 is capable in vitro leading to the production the Beta amyloid protein found in senile plaques and phosphorylating tau protein seen in neurofibrillary tangles seen in Alzheimer’s, a   phenomenon that can be blocked by co-incub

"Testing Strategies Against Lyme Persisters" by Steven LaRosa, MD

Recently I was contacted and interviewed by a party to get my feelings about the state of treatment of Lyme disease. On the phone we lamented about the sizable number of poor souls who continue to suffer symptoms after what is considered standard of care treatment. I made it clear to the interviewer that I practice only evidence-based medicine and that I treat patients based upon the IDSA guidelines. I also railed against physicians who treat patients with months of parenteral antibiotic therapy for “Chronic Limes’ Disease” (ha ha). I stated fairly aggressive and believe that such practices opens the patient to life threatening infections including catheter-related bacteremia and Clostridium difficile colitis. After I got off the phone I started to do some soul searching. I have gotten so used to saying the same lines over and over again, but when was the last time that I actually had looked at the literature? The answer obviously was way too long ago. I was able to identify 5 cli